UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549


                               FORM 8-K

                            CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 22, 2004

           CareDecision Corporation. (OTCBB: CDED)
     (Exact name of Registrant as specified in charter)


           Nevada                000-33187           91-2105842
(State or other jurisdiction    (Commission       (I.R.S. Employer
     of incorporation)          File Number)       Identification)


 2660 Townsgate Road, Suite 300, Westlake Village, CA    91361
      (Address of principal executive offices)         (Zip Code)


Registrant's telephone number, including area code: (805) 446-1973


/1/


ITEM 9. REGULATION FD DISCLOSURE

CareDecision  Corporation ("CareDecision" or the  "Company")
[OTCBB:  CDED] disclosed April 22, 2004 that we are  in  the
latter  stages of negotiation with CareGeneration,  Inc.,  a
leading  distributor  of  pharmaceutical  products   and   a
division   of   Kelly  Co.  World  Group,  Inc.,   for   the
implementation  and on-going support of our  patent  pending
MD@Rx,  MD@Desktop, MD@Practice-Probe and MD@Server products
and  technologies,  to  be  used in  a  nationwide  e-health
initiative.

MD@Rx  is  the pharmaceutical component of our core product,
the  patent-pending wireless MD@HandTM.  MD@RxT, a  clinical
prescription  application, resides on a  wireless  PDA  that
provides  physicians  with  prescribing  information,   drug
interaction  tables, step therapy protocols  and  electronic
prescribing capability at the point of clinical decision.

We expect this proposed alliance with Kelly Co. World Group,
Inc.   to   crystallize  the  completion  of  our  corporate
transformation while concurrently initiating a new stage  in
our   development   and   progression   towards   increasing
shareholder value.

Kelly  Co.  World  Group,  Inc.'s  implementation  of  these
pharmaceutical delivery and e-health initiatives is designed
to  bring  together  the  resources  necessary  to  solve  a
systemic problem in the U.S., providing quality medicine and
care to America's uninsured.  We believe this e-prescription
initiative  and  medication distribution  plan  will  be  of
benefit to many Americans, who the companies believe are not
being serviced by existing e-health initiatives.








Date: April 22, 2004.



CareDecision Corporation


/s/ Keith Berman
-----------------
Keith Berman, CFO


/2/